Top

World Journal of Urology

Published in:

01-12-2013 | Topic Paper

Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications

Authors: James S. Rosoff, Stephen J. Savage, Sandip M. Prasad

Published in: World Journal of Urology | Issue 6/2013

Abstract

Purpose

Management of prostate cancer following radiation therapy remains challenging, especially for younger men or those with life expectancy greater than 10 years. We outline the efficacy, safety and adequacy of radical prostatectomy for the treatment of radiorecurrent localized prostate cancer.

Methods

A systematic review was performed in September 2012 searching MEDLINE articles from 1980 to 2012 on salvage radical prostatectomy. We excluded unpublished data and non-English-language articles.

Results

The ideal candidate for salvage radical prostatectomy (SRP) has a life expectancy greater than 10 years, a PSA < 10 ng/ml and whose initial clinical staging was T1 or T2. A prostate biopsy and imaging studies to rule out metastatic disease should be performed prior to SRP. Salvage RP has a high complication rate, but this appears to be decreasing over time. Urinary continence rates range from 36 to 81 %, whereas erectile function following SRP was generally poor with less than 30 % of men regaining adequate erectile function. Men with good erectile function prior to SRP fared better than those with pre-operative erectile dysfunction. Biochemical recurrence-free probability at 5 years ranged from 37 to 55 % and the estimated cancer-specific survival at 10 years ranged from 70 to 83 %. Minimally invasive SRP is feasible and early outcomes suggest that this approach is not inferior to open surgery.

Conclusion

SRP offers a potentially curative option with proven long-term disease-free survival in appropriately selected patients. Given the morbidity of this procedure, judicious patient selection and referral to providers experienced with salvage surgery may optimize patient outcomes.

Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA: Cancer J Clin 62:10–29

Partin AW, Kattan MW, Subong EN et al (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277:1445–1451PubMedCrossRef

Galper SL, Chen MH, Catalona WJ et al (2006) Evidence to support a continued stage migration and decrease in prostate cancer specific mortality. J Urol 175:907–912PubMedCrossRef

Cooperberg MR, Broering JM, Carroll PR (2010) Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 28:1117–1123PubMedCrossRef

Agarwal PK, Sadetsky N, Konety BR et al (2008) Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 112:307–314PubMedCrossRef

Grossfeld GD, Li YP, Lubeck DP et al (2002) Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol 168:530–535PubMedCrossRef

Van Hemelrijck M, Adolfsson J, Garmo H et al (2010) Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. Lancet Oncol 11:450–458PubMedCrossRef

Keating NL, O’Malley AJ, Freedland SJ et al (2010) Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. J Nat Cancer Inst 102:39–46PubMedCrossRef

Grado GL, Collins JM, Kriegshauser JS et al (1999) Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53:2–10PubMedCrossRef

10.

Chin JL, Touma N, Pautler SE et al (2003) Serial histopathology results of salvage cryoablation for prostate cancer after radiation failure. J Urol 170:1199–1202PubMedCrossRef

11.

Kimura M, Mouraviev V, Tsivian M et al (2010) Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU Int 105:191–201PubMedCrossRef

12.

Lerner SE, Blute ML, Zincke H (1995) Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer. J Urol 154:1103–1109PubMedCrossRef

13.

Rogers E, Ohori M, Kassabian VS et al (1995) Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 153:104–110PubMedCrossRef

14.

Bianco FJ Jr, Scardino PT, Stephenson AJ et al (2005) Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Rad Onc Biol Phys 62:448–453CrossRef

15.

Chade DC, Eastham J, Graefen M et al (2012) Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol 61:961–971PubMedCrossRef

16.

Carson CC 3rd, Zincke H, Utz DC et al (1980) Radical prostatectomy after radiotherapy for prostatic cancer. J Urol 124:237–239PubMed

17.

Rainwater LM, Zincke H (1988) Radical prostatectomy after radiation therapy for cancer of the prostate: feasibility and prognosis. J Urol 140:1455–1459PubMed

18.

Mador DR, Huben RP, Wajsman Z et al (1985) Salvage surgery following radical radiotherapy for adenocarcinoma of the prostate. J Urol 133:58–60PubMed

19.

Vaidya A, Soloway MS (2000) Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited. J Urol 164:1998–2001PubMedCrossRef

20.

Ward JF, Sebo TJ, Blute ML et al (2005) Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 173:1156–1160PubMedCrossRef

21.

Mohler JL, Armstrong AJ, Bahnson RR et al (2012) Prostate cancer, version 3.2012 featured updates to the NCCN guidelines. JNCCN 10:1081–1087PubMed

22.

Sala E, Eberhardt SC, Akin O et al (2006) Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. Radiology 238:176–183PubMedCrossRef

23.

Prasad SM, Gu X, Kowalczyk KJ et al (2012) Morbidity and costs of salvage vs. primary radical prostatectomy in older men. Urol Oncol (epub ahead of print)

24.

Chauhan S, Patel MB, Coelho R et al (2011) Preliminary analysis of the feasibility and safety of salvage robot-assisted radical prostatectomy after radiation failure: multi-institutional perioperative and short-term functional outcomes. J Endourol 25:1013–1019PubMedCrossRef

25.

Prasad SM, Gu X, Lipsitz SR et al (2012) Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States. Cancer 118:1260–1267PubMedCrossRef

26.

Cheng L, Sebo TJ, Slezak J et al (1998) Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer 83:2164–2171PubMedCrossRef

27.

Amling CL, Lerner SE, Martin SK et al (1999) Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 161:857–862PubMedCrossRef

28.

Pisters LL, Leibovici D, Blute M et al (2009) Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol 182:517–525PubMedCrossRef

29.

Paparel P, Cronin AM, Savage C et al (2009) Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. Eur Urol 55:404–410PubMedCrossRef

30.

Chade DC, Shariat SF, Cronin AM et al (2011) Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol 60:205–210PubMedCrossRef

31.

Stephenson AJ, Scardino PT, Bianco FJ Jr et al (2004) Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 172:2239–2243PubMedCrossRef

32.

Masterson TA, Stephenson AJ, Scardino PT et al (2005) Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Urology 66:623–626PubMedCrossRef

33.

Leonardo C, Simone G, Papalia R et al (2009) Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. Int J Urol 16:584–586PubMedCrossRef

34.

Sanderson KM, Penson DF, Cai J et al (2006) Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol 176:2025–2031; discussion 2031–2022

35.

Heidenreich A, Richter S, Thuer D et al (2010) Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy. Eur Urol 57:437–443PubMedCrossRef

36.

Boris RS, Bhandari A, Krane LS et al (2009) Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes. BJU Int 103:952–956PubMedCrossRef

37.

Eandi JA, Link BA, Nelson RA et al (2010) Robotic assisted laparoscopic salvage prostatectomy for radiation resistant prostate cancer. J Urol 183:133–137PubMedCrossRef

38.

Ahallal Y, Shariat SF, Chade DC et al (2011) Pilot study of salvage laparoscopic prostatectomy for the treatment of recurrent prostate cancer. BJU Int 108:724–728PubMed

Title: Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications
Authors: James S. Rosoff
Stephen J. Savage
Sandip M. Prasad
Publication date: 01-12-2013
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 6/2013
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-013-1029-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2013

Semen quality and associated reproductive indicators in middle-aged males: the role of non-malignant prostate conditions and genital tract inflammation

Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry

Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis

Construction of a three-dimensional model of renal stones: comprehensive planning for percutaneous nephrolithotomy and assistance in surgery

Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates

Atherosclerosis within the non-neoplastic margin of partial nephrectomy specimens: implications for medical management